Early transplant related mortality in lymphoma patients undergoing autologous hematopoietic stem cell transplantation after conditioning with CBV (cyclophosphamide, carmustine and etoposide)

被引：0
|
作者：
Regadera, A
Jarque, I
de la Rubia, J
Andreu, R
Garcia, I
Moscardó, F
Mena, A
Yuste, A
Jimenez, C
Martín, G
Martínez, J
Sanz, G
Saavedra, S
Mollá, S
Plumé, G
Sanz, MA
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S264 / S264
页数：1
相关论文
共 50 条
  • [1] BACE (Bendamustine, Cytarabine, Cyclophosphamide and Etoposide) conditioning regime for patients with lymphoma undergoing autologous stem cell transplant
    Chakrabartty, Joydeep
    Bishnu, Arijit
    Bhojgaria, Akash
    Panmei, Sara
    Das, Mihir
    Devi, Keisam Sanjita
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024,
  • [2] Outcome of CBV (Carmustine, Cyclophosphamide, Etoposide) Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma: A Retrospective Study from a Tertiary Cancer Center in South India
    Krishnamoorthi, Narendran
    Prakash, Bhanu
    Dhanraju, K. M.
    Pani, Chinmaya Kumar
    Ram, Malliha
    Rajesh, Kalpana
    Dubashi, Biswajit
    Ganesan, Prasanth
    Kayal, Smita
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2022,
  • [3] LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma
    Kelli Borges dos Santos
    Luciano José Megale Costa
    Gustavo Bettarello
    Marcus da Matta Abreu
    Graziela Toledo Costa Mayrink
    Mariza Aparecida Mota
    Luiz Cláudio Ribeiro
    Juliana Pereira
    Abrahão Elias Hallack Neto
    Bone Marrow Transplantation, 2019, 54 : 625 - 628
  • [4] LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma
    dos Santos, Kelli Borges
    Costa, Luciano Jose Megale
    Bettarello, Gustavo
    Abreu, Marcus da Matta
    Costa Mayrink, Graziela Toledo
    Mota, Mariza Aparecida
    Ribeiro, Luiz Claudio
    Pereira, Juliana
    Hallack Neto, Abrahao Elias
    BONE MARROW TRANSPLANTATION, 2019, 54 (04) : 625 - 628
  • [5] Autologous hematopoietic stem cell transplantation (ASCT) outcomes in non-Hodgkin lymphoma (NHL) patients undergoing high dose therapy (HDT) with etoposide, cyclophosphamide and thiotepa (VP/CY/TT) versus cyclophosphamide, carmustine and etoposide (CBV)
    Veltri, L. W.
    Shah, N.
    Cumpston, A.
    Zhang, J.
    Wen, S.
    Watkins, K.
    Leadmon, S.
    Craig, M.
    Hamadani, M.
    Kanate, A. S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S238 - S238
  • [6] BUSULFAN, CYCLOPHOSPHAMIDE, ETOPOSIDE (BUCYVP) OR CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHELAN (BEAM) FOR CONDITIONING PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN PATIENTS WITH HODGKIN LYMPHOMA (HL)?
    Salem, G.
    Ruppert, A. S.
    Efebera, Y.
    Elder, P.
    Bingman, A.
    Penza, S.
    Andritsos, L. A.
    Devine, S. M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S246 - S246
  • [7] Busulfan, cyclophosphamide, etoposide is not superior to carmustine, etoposide, cytarabine, mephalan conditioning prior to autologous stem cell transplantation in patients with Hodgkin's lymphoma and is associated with increased toxicity
    Salem, G.
    Dunavin, N.
    Wei, L.
    Elder, P.
    Penza, S.
    Blum, K.
    Porcu, P.
    Baiocchi, R.
    Jones, J.
    Flynn, J.
    Andritsos, L.
    Devine, S. M.
    Christian, B.
    Efebera, Y.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S84 - S85
  • [8] Bendamustine Based Conditioning Regime (BACE-Bendamustine, Cytarabine, Cyclophosphamide and Etoposide) for Patients with Lymphoma Undergoing Autologous Stem Cell Transplant
    Jain, Neelesh
    Chakravarti, Amrita
    Sood, Nitin
    Arabandi, Anil
    Sengupta, Kasturi
    Chakrabartty, Joydeep
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S121 - S122
  • [9] Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma
    M Benekli
    S L Smiley
    T Younis
    M S Czuczman
    F Hernandez-Ilizaliturri
    B Bambach
    M Battiwalla
    S Padmanabhan
    P L McCarthy
    T Hahn
    Bone Marrow Transplantation, 2008, 41 : 613 - 619
  • [10] Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma
    Benekli, M.
    Smiley, S. L.
    Younis, T.
    Czuczman, M. S.
    Hernandez-Ilizaliturri, F.
    Bambach, B.
    Battiwalla, M.
    Padmanabhan, S.
    McCarthy, P. L., Jr.
    Hahn, T.
    BONE MARROW TRANSPLANTATION, 2008, 41 (07) : 613 - 619
12345